Topic

postmarket surveillance

Every THE D[AI]LY BRIEF article on postmarket surveillance — enterprise AI analysis, benchmarks, vendor comparisons, and ROI frameworks for technology and business leaders. Updated as new coverage publishes.

clinical AI validation

FDA Cleared 1,357 AI Devices. Three Were Tested on Patients.

A PLOS Digital Health analysis found that only 3 of 1,357 FDA-cleared AI/ML medical devices were ever evaluated on patient outcomes. Clearance certifies substantial equivalence to a predicate, not benefit — so health systems have to write the evidence, subgroup coverage and drift monitoring into procurement themselves.

August 19, 2026 · 11 min read